{"id":"W2724638186","doi":"10.1182/blood-2017-01-762336","title":"Gemtuzumab ozogamicin in infants with AML: results from the Children’s Oncology Group trials AAML03P1 and AAML0531","year":2017,"lang":"en","type":"review","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Gemtuzumab ozogamicin; Medicine; Oncology; Internal medicine; Myeloid leukemia; Leukemia; Pediatrics; Clinical trial; CD33","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002196167,0.0004577981,0.001485422,0.0007644887,0.0002304474,0.000913626,0.001113149,0.001380017,0.003288224],"category_scores_gemma":[0.006090203,0.0001460473,0.0006553715,0.001246771,0.0002778497,0.0011003,0.0004913641,0.002274971,0.0008412067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004483782,"about_ca_system_score_gemma":0.001773264,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005815391,"about_ca_topic_score_gemma":0.001491921,"domain_scores_codex":[0.9993075,0.0002688631,0.0001284276,0.00006682034,0.000188587,0.00003977821],"domain_scores_gemma":[0.9977251,0.001159785,0.0003902862,0.00002711424,0.000579745,0.0001180339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0009878949,0.00004288147,0.0004662766,0.04799952,0.0006770072,0.0003009353,0.00011675,0.0001949177,0.0005630063,0.002214799,0.3821553,0.5642807],"study_design_scores_gemma":[0.0004791068,0.0003197855,0.001280987,0.0256047,0.001750091,0.001040464,0.0001153389,0.0001555241,0.0004792585,0.001890677,0.9668395,0.00004459244],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003799389,0.9798232,0.0000755298,0.01189877,0.006986107,0.00001555806,0.0001077599,0.000011276,0.0007019057],"genre_scores_gemma":[0.00352315,0.974296,0.0001829884,0.01128789,0.009134003,0.00002611286,0.0001509719,0.000008246851,0.001390503],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003288224,"threshold_uncertainty_score":0.01161456,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1302847990664755,"score_gpt":0.416543857673311,"score_spread":0.2862590586068355,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}